Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001663577-22-000372
Filing Date
2022-06-10
Accepted
2022-06-10 17:08:48
Documents
43
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 abti10k.htm   iXBRL 10-K 766714
2 GRAPHIC image_001.jpg GRAPHIC 2736
3 GRAPHIC image_002.jpg GRAPHIC 3960
4 GRAPHIC image_003.jpg GRAPHIC 5096
10 ex31_1.htm EX-31.1 8997
11 ex31_2.htm EX-31.2 9000
12 ex32_1.htm EX-32.1 5012
  Complete submission text file 0001663577-22-000372.txt   2464753

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE abti-20220331.xsd EX-101.SCH 17008
6 XBRL CALCULATION FILE abti-20220331_cal.xml EX-101.CAL 31621
7 XBRL DEFINITION FILE abti-20220331_def.xml EX-101.DEF 44367
8 XBRL LABEL FILE abti-20220331_lab.xml EX-101.LAB 146946
9 XBRL PRESENTATION FILE abti-20220331_pre.xml EX-101.PRE 121054
37 EXTRACTED XBRL INSTANCE DOCUMENT abti10k_htm.xml XML 158299
Mailing Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR
Business Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR 44 151 601 9477
ALTEROLA BIOTECH INC. (Filer) CIK: 0001442999 (see all company filings)

EIN.: 821317032 | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 333-156091 | Film No.: 221009811
SIC: 2833 Medicinal Chemicals & Botanical Products